BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30910650)

  • 1. Higher Inpatient Mortality for Women after Intervention for Lifestyle Limiting Claudication.
    Miller SM; Sumpio BJ; Miller MS; Erben Y; Cordova AC; Sumpio BE
    Ann Vasc Surg; 2019 Jul; 58():54-62. PubMed ID: 30910650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease.
    Lo RC; Bensley RP; Dahlberg SE; Matyal R; Hamdan AD; Wyers M; Chaikof EL; Schermerhorn ML
    J Vasc Surg; 2014 Feb; 59(2):409-418.e3. PubMed ID: 24080134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of open and endovascular lower extremity revascularization in active smokers with advanced peripheral arterial disease.
    Chen SL; Whealon MD; Kabutey NK; Kuo IJ; Sgroi MD; Fujitani RM
    J Vasc Surg; 2017 Jun; 65(6):1680-1689. PubMed ID: 28527930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mortality in octogenarians treated for lifestyle limiting claudication.
    Erben Y; Mena-Hurtado CI; Miller SM; Jean RA; Sumpio BJ; Velasquez CA; Mojibian H; Aruny J; Dardik A; Sumpio BE
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1331-1338. PubMed ID: 29405592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nationwide Trends of Hospital Admission and Outcomes Among Critical Limb Ischemia Patients: From 2003-2011.
    Agarwal S; Sud K; Shishehbor MH
    J Am Coll Cardiol; 2016 Apr; 67(16):1901-13. PubMed ID: 27012780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial disease.
    Vouyouka AG; Egorova NN; Salloum A; Kleinman L; Marin M; Faries PL; Moscowitz A
    J Vasc Surg; 2010 Nov; 52(5):1196-202. PubMed ID: 20674247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major adverse limb events and major adverse cardiac events after contemporary lower extremity bypass and infrainguinal endovascular intervention in patients with claudication.
    Fashandi AZ; Mehaffey JH; Hawkins RB; Kron IL; Upchurch GR; Robinson WP
    J Vasc Surg; 2018 Dec; 68(6):1817-1823. PubMed ID: 30470369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationally Representative Readmission Factors in Patients with Claudication and Critical Limb Ischemia.
    Martinez RA; Shnayder M; Parreco J; Gaffney L; Eby M; Cortolillo N; Lopez M; Zeltzer J
    Ann Vasc Surg; 2018 Oct; 52():96-107. PubMed ID: 29777842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-Year Readmission after Open and Endovascular Revascularization for Critical Limb Ischemia.
    Ochoa Chaar CI; Gholitabar N; Goodney P; Dardik A; Abougergi MS
    Ann Vasc Surg; 2019 Nov; 61():25-32.e2. PubMed ID: 31376536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of the outcomes of a decade of experience with lower extremity revascularization including limb salvage, lengths of stay, and safety.
    Egorova NN; Guillerme S; Gelijns A; Morrissey N; Dayal R; McKinsey JF; Nowygrod R
    J Vasc Surg; 2010 Apr; 51(4):878-85, 885.e1. PubMed ID: 20045618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions.
    Bodewes TC; Soden PA; Ultee KH; Zettervall SL; Pothof AB; Deery SE; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 Feb; 65(2):484-494.e3. PubMed ID: 28126175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-hospital versus postdischarge major adverse events within 30 days following lower extremity revascularization.
    Liang P; Li C; O'Donnell TFX; Lo RC; Soden PA; Swerdlow NJ; Schermerhorn ML
    J Vasc Surg; 2019 Feb; 69(2):482-489. PubMed ID: 30301689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy in Outcomes after Revascularization for Chronic Limb-Threatening Ischemia Warrants Separate Reporting of Rest Pain and Tissue Loss.
    Brahmandam A; Gholitabar N; Cardella J; Nassiri N; Dardik A; Georgi M; Ochoa Chaar CI
    Ann Vasc Surg; 2021 Jan; 70():237-244. PubMed ID: 32659417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia Increases Mortality After Open or Endovascular Treatment in Patients with Critical Limb Ischemia: A Retrospective Analysis.
    Velescu A; Clará A; Cladellas M; Peñafiel J; Mateos E; Ibañez S; Mellado M
    Eur J Vasc Endovasc Surg; 2016 Apr; 51(4):543-9. PubMed ID: 26810343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft.
    Sachs T; Pomposelli F; Hamdan A; Wyers M; Schermerhorn M
    J Vasc Surg; 2011 Oct; 54(4):1021-1031.e1. PubMed ID: 21880457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary comparison of aortofemoral bypass to alternative inflow procedures in the Veteran population.
    McPhee JT; Madenci A; Raffetto J; Martin M; Gupta N
    J Vasc Surg; 2016 Dec; 64(6):1660-1666. PubMed ID: 27462000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of coexisting aneurysms on open revascularization for aortoiliac occlusive disease.
    Daniel VT; Gupta N; Raffetto JD; McPhee JT
    J Vasc Surg; 2016 Apr; 63(4):944-8. PubMed ID: 26843353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and perioperative outcomes of patients with human immunodeficiency virus (HIV) undergoing lower extremity revascularization.
    Kim TI; Brahmandam A; Sarac TP; Orion KC
    Vasc Med; 2020 Dec; 25(6):527-533. PubMed ID: 33019909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative beta blockade is associated with increased rates of 30-day major adverse cardiac events in critical limb ischemia patients undergoing infrainguinal revascularization.
    Shannon AH; Mehaffey JH; Cullen JM; Hawkins RB; Roy R; Upchurch GR; Robinson WP
    J Vasc Surg; 2019 Apr; 69(4):1167-1172.e1. PubMed ID: 30598355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.